Not Yet Recruiting
A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
NCT07432022
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, Combination Therapy, EMB07, +1 more
- Locations
-
Not specified